Associated Papers
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC et al.
Scientific Reports, 2022
35264596 (PubMed )
Supplement: 41598_2022_7383_MOESM3_ESM.xlsx › Planilha1
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients.
Koczkowska M et al.
Cancers, 2018
30441849 (PubMed )
Supplement: cancers-10-00442-s001.pdf
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Balmaña J et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2016
RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.
Krivokuca A et al.
Cancer Biomarkers : Section a of Disease Markers, 2015
RAD51C is a susceptibility gene for ovarian cancer.
Pelttari LM et al.
Human Molecular Genetics, 2011
Select a paper to view details